Skip to main content
ASLAN Pharmaceuticals Limited (ASLN)
NASDAQ: ASLN · IEX Real-Time Price · USD
0.457
-0.003 (-0.63%)
At close: May 1, 2024, 4:00 PM
0.450
-0.007 (-1.55%)
After-hours: May 1, 2024, 7:40 PM EDT

ASLAN Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current20232022202120202019201820172016
Market Capitalization
8925787065121--
Market Cap Growth
--64.23%-67.82%12.23%6.86%-46.09%---
Enterprise Value
14156197562106-41-43
PE Ratio
-0.20-0.20-0.49-2.47-4.10-1.38-2.86--
PS Ratio
0.670.75---21.69---
PB Ratio
-0.68-0.683.001.36-6.65-38.793.94--
P/FCF Ratio
-0.21-0.21-0.70-2.29-4.62-2.55-1.92--
P/OCF Ratio
-0.21-0.21-0.70-2.30-4.62-2.55-3.04--
EV/Sales Ratio
1.141.22---20.50---3.76
EV/EBITDA Ratio
-0.37-0.37-0.13-0.65-4.83-1.36-2.551.045.14
EV/EBIT Ratio
-0.37-0.37-0.12-0.64-4.74-1.34-2.541.045.09
EV/FCF Ratio
-0.34-0.34-0.16-0.56-4.95-2.41-1.681.186.94
Debt / Equity Ratio
-2.03-2.034.510.55-1.87-11.120.460.270.20
Debt / EBITDA Ratio
-0.68-0.68-0.80-1.06-1.27-0.41-0.34-0.25-0.99
Debt / FCF Ratio
-0.62-0.62-1.05-0.92-1.30-0.73-0.22-0.28-1.33
Quick Ratio
1.621.622.4614.181.364.123.618.4613.94
Current Ratio
1.841.842.6314.751.464.143.648.4713.97
Asset Turnover
0.260.260000.0800-
Interest Coverage
-9.18-9.18-12.95-15.98-12.61-50.75-84.73-94.73-16.26
Return on Equity (ROE)
-8453.60%-8453.60%-190.00%-44.90%188.50%-325.30%-127.60%-103.50%-
Return on Assets (ROA)
-95.70%-95.70%-67.30%-31.80%-108.90%-123.50%-81.00%-76.00%-
Return on Capital (ROIC)
-320.96%-320.96%-103.92%-38.21%-181.75%-268.56%-94.97%-86.61%-17.43%
Earnings Yield
-549.75%-492.35%-204.64%-40.49%-24.41%-72.34%-34.95%--
FCF Yield
-538.70%-482.45%-143.34%-43.63%-21.65%-39.20%-52.04%--
Buyback Yield / Dilution
-23.32%-23.32%-7.07%-69.43%-18.37%-8.45%10.67%--
Total Shareholder Return
-23.32%-23.32%-7.07%-69.43%-18.37%-8.45%10.67%--
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).